NICE recommends Pierre Fabre’s Nerlynx in adjuvant HER2+ breast cancer
August 7, 2019Research and Development, Sales and Marketing Cancer, NCIE, NHS, Nerlynx, Pierre Fabre, UK, breast cancer
Pierre Fabre’s Nerlynx (neratinib) has been recommended by NICE as a new option for NHS patients with early hormone-receptor-positive, human …
Medicinal cannabis company Spectrum makes first shipment into UK
August 7, 2019Research and Development Spectrum, UK, cannabis, medicinalcannabis, pharma
Medicinal cannabis company Spectrum Europe has made its first shipment of cannabis into the UK, making it one of the …
Novartis hid faulty data from FDA over $2.1 million gene therapy Zolgensma
August 7, 2019Research and Development AveXis, FDA, Novartis, Zolgensma, gene therapy, pharma
Novartis hid faulty data from the FDA until their drug was approved, according to a statement from Dr Peter Marks, …
Troy Robinson promoted to managing director of Chugai Pharma Europe
August 6, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Troy Robinson has been taken on as the new managing director of Chugai Pharma Europe. Mike Crosher will succeed him …
Lilly’s Emgality smashes all Phase 3 endpoints in migraine sub-population
August 6, 2019Manufacturing and Production, Research and Development Eli Lilly, Emgality, migraine, pharma
New Phase 3 data have been revealed on Eli Lilly’s Emgality (galcanezumab-gnlm), detailing its success in meeting all of its …
NICE reject Clovis Oncology’s ovarian cancer drug Rubraca
August 6, 2019Manufacturing and Production NHS, NICE, Rubraca, UK, guidance, pharma
Britain’s cost-effectiveness body NICE has chosen not to recommend Clovis Oncology’s cancer drug Rubraca (rucaparib). On 6 August, NICE issued …
Takeda signs deal with Sosei Heptares worth $1.2 billion
August 6, 2019Manufacturing and Production GPCR, Sosei Heptares, Takeda, pharma, sosei
Takeda has entered into a partnership with Sosei Heptares to develop drugs that modulate G protein-coupled receptor (GPCR) targets. The …
Sanofi’s Dupixent extended in Europe to cover adolescents in atopic dermatitis
August 6, 2019Manufacturing and Production, Sales and Marketing EU, Europe, Sanofi, atopic dermatits, pharma
Sanofi has announced that European Commission (EC) has chosen to extend the marketing approval of its interleukin-4 (IL-4) and interleukin-13 …
Pfizer’s sickle cell drug flops at Phase 3 trial
August 6, 2019Manufacturing and Production, Sales and Marketing Pfizer, Sickle cell, clinical trials, pharma, reset
Pfizer has said its sickle cell drug rivipansel failed to meet its primary endpoint or key secondary endpoints in a …
Living with a rare genetic neurodevelopmental disorder
August 5, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing KAT6A, feature, patient experience, pharma, rare disease
Vaila Morrison’s daughter Eilidh was born with the ultra-rare condition KAT6A. As a designer and architect by profession, Vaila told …
Additional data for Boehringer’s Giotrif combo shows strong overall survival benefit in lung cancer sub-population
August 5, 2019Research and Development, Sales and Marketing Boehringer Ingelheim, Cancer, giotrif, lung cancer, pharma
German firm Boehringer Ingelheim has released new interim data from a real-world evidence study investigating the efficacy of Giotrif/Gilotrif (afatinib) …
New model can help predict cognitive decline in patients with Alzheimer’s
August 5, 2019Sales and Marketing Alzheimer's pharma, cognitive decline, computing, dementia, pharma
Scientists at MIT have developed a new model which can predict whether patients at risk for Alzheimer’s disease will experience …
Pollen spores could be used to protect potent, ocean-dwelling antibiotics in fighting antibiotic resistant superbugs
August 5, 2019Research and Development, Sales and Marketing AMR, Antibiotics, MRSA, club moss, pharma, pollen, spores
Spores from a plant called the common club moss (Lycopodium clavatum) could be used to protect light-sensitive antibiotics, that are …
Daiichi Sankyo’s Turalio becomes first FDA-approved therapy for rare tumour
August 5, 2019Sales and Marketing Cancer, Daiichi Sankyo, FDA, Turalio, US, pharma, rare cancer
Daiichi Sankyo has seen its CSF1R inhibitor Turalio (pexidartinib) approved by the FDA in the treatment of symptomatic tenosynovial giant …
Roche’s Tecentriq meets primary endpoint in Phase 3 bladder cancer trial
August 5, 2019Sales and Marketing Cancer, Roche, bladder cancer, immunotherapy, oncology, tecentriq
Roche has said its immunotherapy drug Tecentriq (Atezolizumab), when used in combination with platinum-based chemotherapy, significantly reduced the risk of …
Top UK doctors warn Boris Johnson that no-deal Brexit would cause key cancer therapy supply shortages
August 2, 2019Manufacturing and Production, Medical Communications Cancer, NHS, UK, brexit, pharma
Top doctors from some of the UK’s foremost nuclear medicine associations have written a letter to recently-anointed Prime Minister Boris …
Dr Wajid Hussain appointed new clinical director for digital health at RCP
August 2, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing IT, RCP, Royal College of Physicians, digital health, pharma
The Royal College of Physicians (RCP) has appointed Dr Wajid Hussain as its new clinical director for digital health. Dr …
Top Ten most popular articles on Pharmafile.com this week!
August 2, 2019Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pfizer dominated the headlines this week as the US firm closed its $9.8 billion merger with GSK and announced that …
AI accurately detects subtle signs of atrial fibrillation even in normal tests
August 2, 2019Medical Communications AF, AI, ECG, atrial fibrillation, electrcardiogram, pharma
A new study from the Mayo Clinic shows that artificial intelligence (AI) can detect signs of atrial fibrillation (AF) in …
European approval for two new delivery formulations of GSK’s Nucala in severe eosinophilic asthma
August 2, 2019Medical Communications, Sales and Marketing Europe, GSK, Nucala, asthma, pharma
Following closely on the heels of the news that its deal to merge Pfizer’s consumer health business with its own, …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
